Which has grown faster, CCCC or SMTI?

Over the past five years, SMTI grew revenue faster — CCCC at a 0.65% CAGR versus SMTI at 40.06%.

How have CCCC and SMTI total returns compared?

Over the past 5 years, CCCC delivered -41.77% and SMTI delivered 0.35% annualized total return. Past performance doesn't predict future results.

C4 Therapeutics, Inc. (CCCC) vs Sanara MedTech Inc. (SMTI)

A side-by-side comparison of C4 Therapeutics, Inc. and Sanara MedTech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CCCC

C4 Therapeutics, Inc.

$315M

$2.85HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

SMTI

Sanara MedTech Inc.

$322M

$35.00HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT

Total return — CCCC vs SMTI

growth of $100 · dividends reinvested · last 6y

CCCC -88.3% (-30.0%/yr)SMTI +44.3% (+6.3%/yr)SMTI compounded faster over this window

Log scale — wide-divergence pair

CCCC SMTI

CCCC vs SMTI: by the numbers

•SMTI is the larger company ($322M vs $315M market cap).
•Both run net losses; SMTI's is the smaller (-29.15% vs -289.44% net margin).
•SMTI grew revenue faster over the past five years (40.06% vs 0.65% CAGR).

Metrics side by side

Valuation

Metric	CCCC	SMTI
Forward P/E	N/A	184.21
P/S ratio	8.98	2.93
P/B ratio	1.27	40.51
EV / EBITDA	N/A	27.80
FCF yield	N/A	1.40%

Profitability

Metric	CCCC	SMTI
Gross margin	77.81%	91.33%
Operating margin	-290.68%	9.36%
Net margin	-289.44%	-29.15%
ROE	-41.02%	-403.03%
ROIC	-35.92%	18.15%

Growth (annualized)

Metric	CCCC	SMTI
Revenue CAGR (5Y)	0.65%	40.06%
Total return CAGR (5Y)	-41.77%	0.35%

Frequently asked

Which has grown faster, CCCC or SMTI?: Over the past five years, SMTI grew revenue faster — CCCC at a 0.65% CAGR versus SMTI at 40.06%.
How have CCCC and SMTI total returns compared?: Over the past 5 years, CCCC delivered -41.77% and SMTI delivered 0.35% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CCCC analysis Full SMTI analysis Interactive comparison tool

Dig into the metrics

C4 Therapeutics ROE Sanara MedTech ROE C4 Therapeutics operating margin Sanara MedTech operating margin C4 Therapeutics revenue growth Sanara MedTech revenue growth C4 Therapeutics free cash flow Sanara MedTech free cash flow

C4 Therapeutics & Sanara MedTech appear in these rankings

Fastest Revenue Growth Stocks Highest ROIC Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.